EphA2 Antibody

About the Target

EPHA2 is a target of interest in many antibody-based workflows. Eph receptor protein tyrosine kinases (RPTKs) constitute the largest subfamily of RPTKs, with 16 members in vertebrates (14 in humans). They are categorized into EphA and EphB kinases based on sequence homology and ligand binding specificity to ephrins. EphA kinases bind to GPI-anchored ephrin-As, while EphB kinases target transmembrane ephrin-Bs. Depending on the literature source, EPHA2 may also be discussed as Eck/EphA2.

Reported cellular context includes cell junction, cell membrane, cell projection, and membrane, which can matter when signal is compared across treatments or changing cell states. Following EPHA2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

EPHA2 is commonly interpreted in the context of cancer, neuroscience, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell junction, cell membrane, and cell projection, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell junction, cell membrane, and cell projection across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for EPHA2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in EPHA2 reflect biology rather than handling. When interpreting EPHA2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep EPHA2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.